The inhibition of ALDH2 with daidzin and CVT-10216 significantly inhibited mesenchymal stromal cell (MSC)-induced ALDH activity in AML cells and sensitized them to chemotherapy [48]. This evidence concerns the gene ALDH2 and acute myeloid leukemia.